Why the study?
Does endogenous digoxin-like immunoreactive substance correlate with potassium levels to trigger nonoliguric hyperkalemia in premature infants?
Does endogenous digoxin-like immunoreactive substance correlate with potassium levels to trigger nonoliguric hyperkalemia in premature infants?
Endogenous digoxin-like immunoreactive substance does not appear to play a major role in triggering nonoliguric hyperkalemia in premature infants.
Challenges role of DLIS in nonoliguric hyperkalemia of prematurity; leaves open alternative etiologies for prospective study.
Nonoliguric hyperkalemia of premature infants probably results from a transient inhibition of membrane-bound Na+/K+-ATPase during the first 24 h after birth. We hypothesized that the endogenous digitalis-like activity of the serum of premature infants, which inhibits the Na+/K+-ATPase, triggered hyperkalemia. Serum concentrations of potassium ([K+]) and of the digoxin-like immunoreactive substance ([DLIS]) were measured during the first 24 h after birth in 60 infants including 30 infants <30 gestational weeks. Contrary to our hypothesis, there was a negative linear correlation between [DLIS] at birth and [K+] 24 h after birth (r2 = 0.24, p < 0.002). 24 h after birth there was no correlation between [DLIS] and [K+]. Thus, a major role of DLIS in nonoliguric hyperkalemia could not be established.
No takes yet. Share an insight, caveat, or question.
Mildenberger et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: